Clinical trial
MR-Lymphography and Lymph Node Staging in Prostate Cancer
NCT00185029 · Radboud University Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00185029 |
|---|---|
| Title | MR-Lymphography and Lymph Node Staging in Prostate Cancer |
| Official title | MRI With a Lymph Node Specific Contrast Agent: an Alternative for CT-Scanning and Lymph Node Dissection in Patients With Prostate Cancer? |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | ZonMw: The Netherlands Organisation for Health Research and Development |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms, Lymphatic Metastasis |
| Intervention type | Procedure |
| Interventions | Ferumoxtran-10 enhanced MRI (MRL) |
| Enrollment | 396 |
| Start date | Apr 1, 2002 |
| Completion | Aug 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: